Skip to content

RP PHARMA

Active Private limited companyfounded 2025active for 1 yearGroenejagersstraat 32, 1653 BeerselKBO/BCE: BE 1024.554.877

Lifetime

1 annual account with figures
peak of €43,850 in 2025
€43,850 
peak of €32,707 in 2025
€32,707 
peak of €33,707 in 2025
€33,707 
€57,870 
Board1 name since 2025
1 director
Documentsfilings and deeds
06-07-202625 days before the deadline
2025micro format
Incorporation 24-061 establishment registeredFirst year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €200,000 estimated

The micro format states no turnover.

Position in the sector

€32,707

Higher net result than 81% of companies in retail trade. The sector median is €4,724, over 25,359 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 11,279 companies had the same profile as RP PHARMA has now. Each dot stands for 29 companies, two years later.

96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 11,279 companies, not a prediction for RP PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 24-06-2025
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1024554877
Incorporation Founding capital of €1,000, 100 shares · Founded by · appointed as director · published on 24-06-2025 · Gazette deed
First establishment Groenejagersstraat 32, Beersel
All 4 events

Comparable companies

same main activity, similar in size and age
Company
RP PHARMA Beersel €91,576 €43,850 36.8% -
NED PHARMA Mons €74,278 €36,933 31.1% -
T.R.F. pharma Fléron €70,151 €42,395 66.4% -
Charlotte Slabbinck Oudenburg €72,938 €36,678 36.2% -
ESPharma Anderlecht €74,825 €51,161 74.2% -
FARMACYZE Ostend €73,863 €42,761 66.9% -
ES PHARMA Mol €84,690 €49,163 55.3% -

These companies have the same main activity as RP PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €70,200 and €84,700, founded between 2024 and 2025.

Official details

Source: KBO
Status
Active since 20-06-2025Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.375.606.4121653 Beersel, since 20-06-2025
Financial year end
31 December
Peppol
Reachable since 15-12-2025
Company details

Annual accounts 2025

€91,576
Filing
Filed on 06-07-2026, 25 days before the end of the filing period
Financials

Insights on RP PHARMA

RP PHARMA has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €33,707 and a net result of €32,707.

Its solvency ranks better than 53% of 25,388 sector peers (NACE 47) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about RP PHARMA

What is the company number of RP PHARMA?
The company number of RP PHARMA is 1024.554.877. The VAT number is the same number with BE in front: BE 1024.554.877.
Where is RP PHARMA based?
The registered office is at Groenejagersstraat 32, 1653 Beersel.Company details
What does RP PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of RP PHARMA?
RP PHARMA is a private limited company (BV).
When was RP PHARMA founded?
RP PHARMA was founded on 20-06-2025.
Is RP PHARMA still active?
Yes, RP PHARMA is an active enterprise in the KBO register.
What is the turnover of RP PHARMA?
The turnover in financial year 2025 is about €200,000. This figure is estimated from the gross margin of €43,850 and 56 comparable companies (NACE 477). It probably lies between €110,000 and €360,000.Financials
Is RP PHARMA profitable?
In financial year 2025, RP PHARMA made a profit of €32,707.
Where can I find the annual accounts of RP PHARMA?
RP PHARMA filed 1 annual account with the National Bank of Belgium, for financial year 2025.
When are the next annual accounts of RP PHARMA due?
RP PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.